Pharma-Bio Serv (PBSV) Liabilities from Discontinued Operations (2017)
Pharma-Bio Serv (PBSV) reported Liabilities from Discontinued Operations of 110206.0 for Q4 2017.
Pharma-Bio Serv (PBSV) Liabilities from Discontinued Operations (2017) Analysis & Trends
Pharma-Bio Serv's Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 110206.0 for Q4 2017.
- Liabilities from Discontinued Operations for Q4 2017 came in at 110206.0, changed N/A year-over-year; the trailing twelve-month figure through Oct 2017 was 110206.0 (changed N/A YoY), and the FY2017 annual result was 110206.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations came in at 110206.0 for Q4 2017 at Pharma-Bio Serv.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 110206.0 in Q4 2017 to a low of 110206.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2017 | 110,206.00 |
| Oct 31, 2017 | 110,206.00 |